Albireo Consolidated Income from 2010 to 2023

Summary

ALBODelisted Stock

USD 44.15 0.75 1.67%

Albireo Pharma Consolidated Income yearly trend continues to be very stable with very little volatility. Consolidated Income is likely to drop to -33,044,921. During the period from 2010 to 2023, Albireo Pharma Consolidated Income quarterly data regression pattern had range of 100,865,000 and median of (20,747,000). Albireo Pharma Weighted Average Shares is very stable at the moment as compared to the past year. Albireo Pharma reported last year Weighted Average Shares of 22.1 Million. As of 1st of April 2023, Weighted Average Shares Diluted is likely to grow to about 23.8 M, while Consolidated Income is likely to drop (33 M).

Check Albireo Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Albireo main balance sheet or income statement drivers, such as Direct Expenses of 1.2 M, Cost of Revenue of 1.2 M or Gross Profit of 48.7 M, as well as many exotic indicators such as Long Term Debt to Equity of 0.0502, PPandE Turnover of 67.56 or Receivables Turnover of 6.79. Albireo financial statements analysis is a perfect complement when working with Albireo Pharma Valuation or Volatility modules. It can also supplement various Albireo Pharma Technical models . Check out Trending Equities.

Albireo Consolidated Income Breakdown

Showing smoothed Consolidated Income of Albireo Pharma with missing and latest data points interpolated. The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of Net Income Available to Non-controlling Interests.Albireo Pharma's Consolidated Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Albireo Pharma's overall financial position and show how it may be relating to other accounts over time.

Consolidated Income

10 Years Trend

Down

Slightly volatile

Compare to Others All Fundamentals

Consolidated Income

Timeline

Albireo Consolidated Income Regression Statistics

	Arithmetic Mean	(31,673,066)
	Geometric Mean	24,157,435
	Coefficient Of Variation	(83.89)
	Mean Deviation	17,881,513
	Median	(20,747,000)
	Standard Deviation	26,569,716
	Range	100,865,000
	R-Value	(0.51)
	R-Squared	0.26
	Significance	0.07
	Slope	(3,211,341)

Albireo Consolidated Income History

	2023	-33 M
	2022	-30.6 M
	2021	-34 M
	2020	-107.6 M
	2019	-62.7 M
	2018	-46.1 M
	2017	-24.4 M
	2016	-16.4 M
	2014	-6.8 M
	2013	-14.1 M
	2012	-19.3 M

About Albireo Pharma Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Albireo Pharma income statement, its balance sheet, and the statement of cash flows. Albireo Pharma investors use historical funamental indicators, such as Albireo Pharma's Consolidated Income, to determine how well the company is positioned to perform in the future. Although Albireo Pharma investors may use each financial statement separately, they are all related. The changes in Albireo Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Albireo Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Albireo Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Albireo Pharma. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for 2023
Consolidated Income	-30.6 M	-33 M
Net Income Per Employee	-301 K	-324.8 K

Be your own money manager

Our tools can tell you how much better you can do entering a position in Albireo Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Global Markets Map Now

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes

All Next

Launch Module

Pair Trading with Albireo Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Albireo Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Albireo Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving against Albireo Pharma

-	0.83	VALN	Valneva SE ADR	Report 4th of May 2023	Pair Corr
-	0.68	MDWD	Mediwound	Report 16th of May 2023	Pair Corr
-	0.67	CLVSQ	Clovis Oncology		Pair Corr
-	0.66	MDGL	Madrigal Pharmaceuticals	Report 8th of May 2023	Pair Corr
-	0.63	DICE	Dice Molecules Holdings	Report 11th of May 2023	Pair Corr

The ability to find closely correlated positions to Albireo Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Albireo Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Albireo Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Albireo Pharma to buy it.

The correlation of Albireo Pharma is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Albireo Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Albireo Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Albireo Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Check out Trending Equities. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Other Consideration for investing in Albireo Stock

If you are still planning to invest in Albireo Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Albireo Pharma's history and understand the potential risks before investing.

	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Stock Screener Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Transaction History View history of all your transactions and understand their impact on performance

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC